Balaxi Pharmaceuticals vs Nifty 50: Returns Compared

Balaxi Pharmaceuticals vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Balaxi Pharmaceuticals trades on the NSE under the symbol BALAXI, and its 1M return of +2.05% compares with the Nifty 50's -3.66% over the same period.

The Balaxi Pharmaceuticals vs Nifty 50 comparison matters because Balaxi Pharmaceuticals is a single stock exposed to its own sector and company-specific developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Balaxi Pharmaceuticals share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year, 3 years, 5 years, using NSE closing data.

Click Here – Get Free Investment Predictions

Balaxi Pharmaceuticals vs Nifty 50: Performance at a Glance

The table below sets out Balaxi Pharmaceuticals vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 9 September 2026.

Time Frame	Balaxi Pharmaceuticals Return	Nifty 50 Return	Difference
1 Month	+2.05%	-3.66%	+5.71% pp
3 Months	-6.23%	+0.46%	-6.69% pp
6 Months	+29.18%	-5.53%	+34.72% pp
1 Year	-46.74%	-4.61%	-42.13% pp
3 Years	-73.42%	+20.86%	-94.28% pp
5 Years	-78.11% (Balaxi Pharmaceuticals)	+35.35% (Nifty 50)	-113.46% pp

On the Balaxi Pharmaceuticals vs Nifty 50 scorecard, Balaxi Pharmaceuticals has lagged the index over the most recent one-year window. Over the longer term the index has pulled ahead, a reminder that short-term outperformance does not always hold up over multi-year horizons.

Check the Univest Screener for live Balaxi Pharmaceuticals and Nifty 50 data

Why the Balaxi Pharmaceuticals vs Nifty 50 Gap Exists

Balaxi Pharmaceuticals's stock can move quite differently from the Nifty 50 because it carries concentrated exposure to its own sector and business cycle, unlike the index which blends 50 companies across banking, IT, energy and consumer sectors. This is the main driver of the gap seen in the Balaxi Pharmaceuticals vs Nifty 50 return table above.

A second factor behind the Balaxi Pharmaceuticals vs Nifty 50 divergence is valuation and trading liquidity. Company-specific news, quarterly results and sector sentiment can move Balaxi Pharmaceuticals's price sharply in either direction over short periods, while the Nifty 50's return reflects the blended earnings trajectory of its constituents and is far less exposed to any single stock's swings.

Download the Univest iOS App or Univest Android App to track Balaxi Pharmaceuticals and Nifty 50 live on the go.

Balaxi Pharmaceuticals vs Nifty 50: Has Balaxi Pharmaceuticals Beaten the Benchmark?

Balaxi Pharmaceuticals has not kept pace with the Nifty 50 over the past year, posting a return of -46.74% against the index's -4.61% over the same period.

Risks of the Balaxi Pharmaceuticals vs Nifty 50 Comparison

Reading too much into a Balaxi Pharmaceuticals vs Nifty 50 comparison has real limitations that investors should weigh before drawing conclusions. Balaxi Pharmaceuticals carries concentrated business and sector risk that a diversified index does not, and its trading volumes and price swings can differ meaningfully from the Nifty 50's more liquid, blended profile. A stock's 52-week range of Rs 15.20 to Rs 47.87 also shows the kind of volatility that a single-stock investment carries relative to a broad index.

Conclusion

Balaxi Pharmaceuticals vs Nifty 50 highlights how a single stock's return path can differ from a diversified benchmark over different time horizons. Investors weighing the Balaxi Pharmaceuticals vs Nifty 50 record should factor in Balaxi Pharmaceuticals's volatility, liquidity and sector concentration alongside its return history, and consult a SEBI-registered advisor before making an allocation decision.

Has Balaxi Pharmaceuticals outperformed the Nifty 50 in the last year?

Ans. No. Balaxi Pharmaceuticals returned -46.74% over the past year while the Nifty 50 returned -4.61% over the same period, based on NSE closing prices to 9 September 2026.

How does Balaxi Pharmaceuticals vs Nifty 50 look over 5 years?

Ans. Over five years Balaxi Pharmaceuticals has returned -78.11% compared with the Nifty 50's +35.35%, so in the Balaxi Pharmaceuticals vs Nifty 50 comparison the index has been ahead over this longer horizon.

What is the Balaxi Pharmaceuticals share price today compared to Nifty 50?

Ans. Balaxi Pharmaceuticals share price stood at Rs 24.39 on NSE, while the Nifty 50 traded at 23,490.45 based on the same closing data window.

What is the 52-week high and low of Balaxi Pharmaceuticals?

Ans. Balaxi Pharmaceuticals's 52-week high is Rs 47.87 and its 52-week low is Rs 15.20, based on NSE data.

Why does Balaxi Pharmaceuticals show bigger price swings than the Nifty 50?

Ans. Balaxi Pharmaceuticals carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies, so company-specific news moves Balaxi Pharmaceuticals's price more sharply than the diversified index, a key reason the Balaxi Pharmaceuticals vs Nifty 50 return gap varies across time frames.

Is Balaxi Pharmaceuticals a good long-term investment compared to a Nifty 50 index fund?

Ans. Balaxi Pharmaceuticals's suitability depends on an investor's risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund; long-term investors should weigh the Balaxi Pharmaceuticals vs Nifty 50 return history alongside the company's fundamentals and consult a SEBI-registered advisor.